All patients arriving at UCSF’s Emergency Department with heart attack will continue to be treated with standard measures. Patients who meet the medical criteria for the trial will be able to elect to receive the stem cell therapy within seven days after their heart attack.
Researchers at UCSF Medical Center have begun enrollment for an early-stage clinical trial to evaluate the safety and efficacy of an adult stem cell therapy for patients who have just experienced their first acute myocardial infarction, or heart attack.
Researchers at UCSF Medical Center started enrolling patients in an early-stage adult stem cell therapy, developed by Osiris Therapeutics Inc. , for first-time heart attack patients. The two-year Phase II trial — the first stem cell clinical trial …
Bioheart, Inc. (OTCBB: BHRT : ) offers yet another medical breakthrough with the next-level stem cell treatment for cardiac patients. The stem cells aid in limiting damage due to a cardiac event and promote angiogenesis or formation of new blood …
Researchers at UCSF Medical Center have begun enrollment for an early-stage clinical trial to evaluate the safety and efficacy of an adult stem cell therapy for patients who have just experienced their first acute myocardial infarction, or heart attack. The trial is part of a multi-center national study.
Embryonic stem cells provide model; goal is to prevent bone lossAn early laboratory success is taking University of Michigan researchers a step closer to parathyroid gland transplants that could one day prevent a currently untreatable form of bone loss associated with thyroid surgery.The scientists were able to induce embryonic stem cells to differentiate into parathyroid cells that produced a …
The 2009 World Stem Cell Summit concluded a week ago, and since then the sector’s stocks have slipped into the red.
Hikers know that moss on a tree trunk always points north. According to new research by Israeli and German scientists, this ancient plant may also provide a new “compass” for stem cell research, telling scientists how better to program stem cells for medical purposes. Dr. Nir Ohad of Tel Aviv University’s Department of Plant Sciences and Prof.
TEL AVIV, Israel, Sept. 30 (UPI) — Israeli and German scientists say they’ve discovered moss might provide information allowing researchers to better program stem cells for medical purposes.
Hikers know that moss on a tree trunk always points north. According to new research by Israeli and German scientists, this ancient plant may also provide a new “compass” for stem cell research, telling scientists how better to program stem cells for medical purposes.Dr.